$STZ

STZ Maintained by Morgan Stanley -- Price Target Lowered to $145

Morgan Stanley maintained Constellation Brands (STZ) at Equal-Weight but lowered its price target to $145 from $158, citing a cautious outlook in the competitive beverage market. GuruFocus values STZ at $172.88, suggesting a 31.5% undervaluation at its current price of $118.39, with a P/E (TTM) of 10.62x. The company's GF Score is 59/100, indicating moderate overall performance.

Original reporting
Published Oct 8, 2026, 11:34 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 9, 2026, 12:30 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$STZ
Bearish
high confidence
Mentioned
$STZ
Relevance
7/10
AlphAI data visualization · based on gurufocus.com
Decision brief

The 30-second read

$STZBearishMed
01

Why it matters

The analyst's target cut could prompt short‑term selling, but the stock remains undervalued per the GF valuation model.

02

Market read

Target reduction is a fresh analyst action that may influence short‑term price dynamics for STZ and peers in the beverage sector.

03

What to watch

Potential upside from upcoming product launches or cost‑saving initiatives not reflected in the target.

Relevance 7/10Novelty 7/10Timing: today

Background

Constellation Brands is a leading U.S. producer of beer, wine, and spirits with a market cap of ~ $20 bn.

Company-level read

Ticker impact

$STZBearishHigh confidence
Context

Morgan Stanley lowered its price target for Constellation Brands to $145, an 8.2% decrease, while maintaining an Equal‑Weight rating.

Expected impact

likely pressure as the market prices in the target reduction

Evidence & confidence

Target cuts historically trigger short‑term sell pressure, especially when the rating remains neutral.

Market effects

The downgrade may weigh on the broader consumer defensive beverage sector.

U.S. investors may trim exposure to alcoholic beverage stocks.

Limited; impact confined to U.S. equity markets.

Counterpoint

Some investors may see the lower target as a buying opportunity given the stock's current discount to intrinsic value.

Key entities

  • Morgan Stanley

    Equity research firm providing the rating and target update.

  • Constellation Brands

    Producer of alcoholic beverages, ticker STZ.

Related articles

$STZMed

Why is Constellation Brands stock sliding today?

Constellation Brands (STZ) fell 1.1% in pre-market trading after HSBC downgraded it to Hold and cut its price target to $135. The company's Q2 2027 earnings showed mixed results, with adjusted EPS of $3.74 and net sales of $2.63B beating estimates, but beer depletions fell 0.6%. Analysts had mixed reactions, with some cutting price targets but maintaining bullish ratings, while others kept Buy ratings. The broader market downturn also contributed to the slide.